501 related articles for article (PubMed ID: 28306355)
1. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
Greulich T
COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
3. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
5. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
[TBL] [Abstract][Full Text] [Related]
6. Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlook.
Henao MP; Craig TJ
Allergy Asthma Proc; 2017 Mar; 38(2):98-107. PubMed ID: 28234047
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin deficiency: doing the right thing (or start kissing those frogs).
Sandhaus RA
COPD; 2006 Aug; 3(3):123-4. PubMed ID: 17240613
[No Abstract] [Full Text] [Related]
11. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.
Fraughen DD; Ghosh AJ; Hobbs BD; Funk GC; Meischl T; Clarenbach CF; Sievi NA; Schmid-Scherzer K; McElvaney OJ; Murphy MP; Roche AD; Clarke L; Strand M; Vafai-Tabrizi F; Kelly G; Gunaratnam C; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2023 Nov; 208(9):964-974. PubMed ID: 37624745
[No Abstract] [Full Text] [Related]
12. Activity of the alpha-1 antitrypsin deficiency registry in Belgium.
Hutsebaut J; Janssens W; Louis R; Willersinn F; Stephenne X; Sokal E; Derom E
COPD; 2015 May; 12 Suppl 1():10-4. PubMed ID: 25938285
[TBL] [Abstract][Full Text] [Related]
13. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
Rahaghi FF; Monk R; Ramakrishnan V; Beiko T; Strange C
Int J Chron Obstruct Pulmon Dis; 2020; 15():3193-3199. PubMed ID: 33299307
[TBL] [Abstract][Full Text] [Related]
15. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
16. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
McCarthy C; Dimitrov BD
COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
[No Abstract] [Full Text] [Related]
17. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Alpha-1 Antitrypsin Deficiency.
Strange C; Beiko T
Semin Respir Crit Care Med; 2015 Aug; 36(4):470-7. PubMed ID: 26238635
[TBL] [Abstract][Full Text] [Related]
19. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-antitrypsin deficiency: forgotten etiology.
Kaplan A; Cosentino L
Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
